Literature DB >> 18685119

Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question.

Albert Beckers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18685119     DOI： 10.1210/jc.2008-1351

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Pre-surgical treatment with somatostatin analogues in patients with acromegaly: the case against.

Authors:  M Losa; V G Crippa
Journal:  J Endocrinol Invest       Date:  2012-06       Impact factor: 4.256

2.  Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly.

Authors:  Marco Losa; Jens Bollerslev
Journal:  Endocrine       Date:  2016-01-19       Impact factor: 3.633

3.  Management of acromegaly.

Authors:  Vladimir Vasilev; Adrian Daly; Sabina Zacharieva; Albert Beckers
Journal:  F1000 Med Rep       Date:  2010-07-22

4.  Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma.

Authors:  Margreet Albertina E M Wagenmakers; Romana T Netea-Maier; Erik J van Lindert; Gerlach F F M Pieters; André J A Grotenhuis; Ad R M M Hermus
Journal:  Acta Neurochir (Wien)       Date:  2011-02-24       Impact factor: 2.216

Review 5.  Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis.

Authors:  Francisco Pita-Gutierrez; Sonia Pertega-Diaz; Salvador Pita-Fernandez; Lara Pena; Gloria Lugo; Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.